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Abstract
The genetic basis of human neural tube defects (NTDs), such as anencephaly and spina bifida (SB), is complex and
heterogeneous. Grainyhead-like genes represent candidates for involvement in NTDs based on the presence of SB and
exencephaly in mice carrying loss-of-function alleles of Grhl2 or Grhl3. We found that reinstatement of Grhl3 expression, by
bacterial artificial chromosome (BAC)-mediated transgenesis, prevents SB in Grhl3-null embryos, as in the Grhl3
hypomorphic curly tail strain. Notably, however, further increase in expression of Grhl3 causes highly penetrant SB. Grhl3
overexpression recapitulates the spinal NTD phenotype of loss-of-function embryos, although the underlying mechanism
differs. However, it does not phenocopy other defects of Grhl3-null embryos such as abnormal axial curvature, cranial NTDs
(exencephaly) or skin barrier defects, the latter being rescued by the Grhl3-transgene. Grhl2 and Grhl3 can form
homodimers and heterodimers, suggesting a possible model in which defects arising from overexpression of Grhl3 result
from sequestration of Grhl2 in heterodimers, mimicking Grhl2 loss of function. This hypothesis predicts that increased
abundance of Grhl2 would have an ameliorating effect in Grhl3 overexpressing embryo. Instead, we observed a striking
additive genetic interaction between Grhl2 and Grhl3 gain-of-function alleles. Severe SB arose in embryos in which both
genes were expressed at moderately elevated levels that individually do not cause NTDs. Furthermore, moderate Grhl3
overexpression also interacted with the Vangl2Lp allele to cause SB, demonstrating genetic interaction with the planar cell
polarity signalling pathway that is implicated in mouse and human NTDs.
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Introduction
Although neural tube defects (NTDs) are among the most com-
mon birth defects worldwide and have a strong genetic compo-
nent, the specific contributors to genetic risk are not well under-
stood (1,4). Identifying the molecular determinants of human
NTDs is hindered by their complex, multifactorial nature and
likely heterogeneity between cases. Moreover, most cases are
sporadic rather than familial and de novo mutations may also
play a significant role in spina bifida (SB) causation (5,6). Patterns
of recurrence risk support oligogenic or polygenic models in
which most NTDs result from a combination of one or more
genetic factors with contribution from environmental risk fac-
tors, both positive and negative (7). It is anticipated that large-
scale whole-exome and whole-genome sequencing efforts will
provide a greater understanding of the genetic basis of NTDs but
analysis of these large data sets and assignment of causation to
coding variants and/or potential regulatory mutations will not
be trivial.
Candidate genes for human NTDs may be indicated by
knowledge of environmental risk factors, such as folate status
and maternal diabetes, and causative genes in genetic models
of which several hundred have been identified in mice (2,8).
Mouse models have demonstrated a crucial role for members of
the grainyhead-like family of transcription factors in neural tube
closure.Grhl3-null embryos develop fully penetrant SB (9,10) and
a hypomorphic allele of Grhl3 is the main genetic cause of SB
in the curly tail strain (11). Each of these strains also exhibit a
low frequency of exencephaly, which results from incomplete
closure of the cranial neural tube and leads to anencephaly in
late gestation.
Analysis of Grhl3-null and tissue-specific knockout embryos
indicates that the initial defect leading to failure of spinal neu-
rulation is localized to the surface ectoderm component of the
closing neural folds, corresponding with its prominent early
expression in this cell layer (12). Grhl3 is also expressed in the
node-streak border/caudo-lateral epiblast and, later and tran-
siently, in the neuroepithelium as well as in the gut endoderm
(9,11,12). Among these tissues, knockout of Grhl3 in the gut
endoderm causes spinal NTDs, but with later onset than in null
embryos. These defects result from excess ventral curvature of
the body axis, as in curly tail (Grhl3ct) mutant embryos (12,13).
Hence, Grhl3 deficit leads to tissue-specific abnormalities that
inhibit closure at two successive stages of spinal neurulation.
The extent to which GRHL3 mutations may contribute to
human NTDs is not yet clear. Both de novo and rare inherited
missense mutations of GRHL3 have been reported in SB cases
at a frequency that suggests a role in determining NTD predis-
position (6,14).GRHL3mutations have also been reported in indi-
viduals with cleft lip and palate and individuals with syndromic
(Van der Woude syndrome) and non-syndromic isolated cleft
palate (15,17), consistent with GRHL3 expression in the oral
ectoderm. Sharing of a missense mutation in independent SB
and cleft palate cases supports the concept that GRHL3 may
contribute to both defects (6,15).
The potential for regulatory mutations in GRHL3 to con-
tribute to causation of human NTDs has been largely unex-
plored to date. In mice, a regulatory mutation likely underlies
the diminished expression of Grhl3, which causes SB in the curly
tail mouse (11). Tissues from human fetuses with NTDs have
revealed hypomethylation of CpG islands within the 5′UTR and
introns of GRHL3 (18), perhaps suggesting that GRHL3misexpres-
sion may lead to NTDs. In the current study we examined this
possibility in mouse models. Notably, we found that overexpres-
sion of Grhl3 causes a high frequency of severe SB. Moreover,
evenmoderately elevated abundance ofGrhl3was found to cause
SBwhen in combinationwithmutant alleles of other NTD genes:
Grhl2 or Vangl2. Hence, insufficient or excess levels of Grhl3 can
both cause SB.
Results
Overexpression of Grhl3 causes NTDs
Reinstatement of Grhl3 expression, mediated by bacterial arti-
ficial chromosome (BAC) transgenesis, prevents spinal NTDs in
curly tail mice that have partial loss of function of Grhl3 (11).
We investigated the potential effect of increasing levels of Grhl3
expression by intercross of hemizygous Grhl3 BAC-transgenic
mice (Grhl3ct/ct;TgGrhl3/0) to generate litters that include embryos
carrying the BAC in homozygosity (Grhl3ct/ct;TgGrhl3/TgGrhl3). Litters
were genotyped by BAC-specific polymerase chain reaction (PCR)
and quantitative genomic PCR (GqPCR). As in our previous study
(11), Grhl3ct/ct;TgGrhl3/0 embryos (i.e. ct/ct embryos also hemizygous
for the Grhl3-BAC) did not display spinal NTDs, whereas a pro-
portion of Grhl3ct/ct embryos developed SB and/or tail flexion
defects (TFDs) (Fig.1). Remarkably, we observed SB in 67% of
Grhl3ct/ct;TgGrhl3/TgGrhl3 embryos, suggesting that overexpression of
Grhl3 prevents neural tube closure (Fig. 1).
The NTD phenotype of Grhl3 overexpressing embryos could
theoretically result from homozygous insertion of the transgene
into an essential endogenous locus. To investigate this, the
genomic location of the BAC was determined using inverse PCR
(Fig. 2A and B). Sequence analysis indicated that the transgene
insertion site is at position 3,005,382 on chromosome 18, in a
low-complexity region. This was confirmed by PCR amplification
of genomic DNA, using a series of primer pairs located in the
transgene and putative chromosome 18 location (Fig. 2C and
Supplementary Material, Fig. S1A). This site is more than 100 kb
from the nearest recognized gene (vmn1r238) and 266 kb from the
nearest gene (Crem) that has detectable embryonic expression
at E10.5 (Supplementary Material, Fig. S1B). Fluorescence in situ
hybridization (FISH) analysis on whole blood cultures confirmed
that the BAC is present in only one location (Supplementary
Material, Fig. S1D and E). We conclude that insertional muta-
genesis is very unlikely to explain the NTDs observed in Grhl3
overexpressing embryos.
Further evidence that Grhl3 overexpression causes NTDs was
provided by backcross of the Grhl3 transgene onto a wild-type
BALB/c genetic background. NTDs did not occur among wild-
type embryos (n = 20), but among hemizygous (+/+TgGrhl3/0)
embryos we observed a low frequency of SB or TFDs (3/20;
15%). These defects are predicted to arise because the level of
endogenous Grhl3 expression from the wild-type allele is higher
than in the hypomorphic ct strain such that overexpression
mediated by a single copy of the BAC is sufficient to exceed the
level that is compatible with neural tube closure. Consistent
with this, all homozygous (+/+TgGrhl3/TgGrhl3) embryos developed
SB on this genetic background (18/18; 100%).
SB in Grhl3 overexpressing embryos results from early
failure of posterior neuropore closure
In addition to a higher frequency of SB than in Grhl3ct/ct
embryos, the size of the open lesion was also greater in Grhl3
overexpressing embryos at E11.5–13.5 (Fig. 1 and Supplementary
Material, Fig. S2A–D). Previous studies showed that the posterior
neuropore (PNP) length of Grhl3ct/ct embryos becomes larger
than genetically matched wild-type embryos from the 25–27
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Figure 1. Spinal NTDs in Grhl3-transgenic mice. (A) Occurrence of SB among offspring of matings between Grhl3ct/ct;TgGrhl3/0 (BAC-hemizygous) and Grhl3ct/ct mice
analysed at E11.5–18.5 (∗, significant difference from other genotypes; P < 0.001, Chi-square). (B–E) Embryos of the three genotypes at E11.5. All Grhl3ct/ct;TgGrhl3/0
embryos appeared normal with a straight caudal region (C), whereas a proportion of Grhl3ct/ct (B) and Grhl3ct/ct;TgGrhl3/TgGrhl3 (D, E) exhibited TFDs and/or SB (extent of
open region indicated by arrowheads). Scale bar represents 1 mm.
Figure 2. Localization of BAC-transgene in Grhl3ct/ct;TgGrhl3/0 embryos. (A) Inverse
PCR was used to isolate genomic fragments adjacent to the insertion site of the
Grhl3-containing BAC. (B) Sequence tags most closely aligned to the reference
genomic sequence in a region on chromosome 18 with insertion of the BAC at 18:
3,005,382 in a low complexity repeat. Inverse PCR fragments also show homology
to regions on chromosome 16 but with lower identity.
somite stage (E10.5) (11). In order to assess the stage at which
spinal neurulation fails in Grhl3 overexpressing embryos, we
collected litters generated by intercross of Grhl3ct/ct;TgGrhl3/0 mice.
Among embryos analysed at E9–10.5, the PNP length was
already larger among Grhl3ct/ct; TgGrhl3/TgGrhl3 embryos than Grhl3ct/ct
littermates from the 12–15 somite stage (E9) onwards (Fig. 3A
and Supplementary Material, Fig. S2E). This earlier failure of
closure explains why the extent of the open SB lesion is greater
among Grhl3 overexpressing fetuses than in their hypomorphic
littermates.
Among embryos at E9.5 and E10.0, Grhl3 mRNA was
upregulated by 2–3-folds in the caudal region of Grhl3ct/ct; TgGrhl3/0
embryos and 4–6-folds in Grhl3ct/ct; TgGrhl3/TgGrhl3, compared with
Grhl3ct/ct (Fig. 3B). This equates to ∼1.3–1.5- and 2.5–3-fold higher
expression than in wild-type embryos with a similar genetic
background (based on our finding that Grhl3 abundance in ct/ct
embryos is ∼50% of that in partially congenic (+ct/+ct) wild types
(11). Hence,Grhl3mRNA abundance (by qRT-PCR) correlatedwith
the number of copies of the Grhl3 gene, determined by GqPCR
(Fig. 3C). We conclude that during spinal neurulation the PNP
becomes enlarged in Grhl3ct/ct hypomorphic embryos compared
with Grhl3ct/ct; TgGrhl3/0 embryos that have mildly elevated Grhl3
expression, but a further increase in Grhl3 expression results
in an even larger PNP in Grhl3ct/ct; TgGrhl3/TgGrhl3 embryos (Fig. 3D),
resulting in SB. Scanning electron microscopy showed that
the enlarged PNP of Grhl3 overexpressing embryos was char-
acteristically very narrow (compare Fig. 3E–F with Fig. 3G–H),
suggesting that NTDs do not result from a defect in elevation or
bending of the neural folds.
Balance between excess and insufficient expression of
Grhl3 in spinal neurulation
Homozygous embryos for Grhl3-null (Grhl3-/-) or gain-of-function
(Grhl3ct/ct; TgGrhl3/TgGrhl3) alleles develop severe spinal NTDs. In order
to further investigate the correlation between Grhl3 expression
level and neural tube closure we asked whether transgenic
expression was sufficient to rescue Grhl3-null NTDs and/or vice
versa. Grhl3+/- and Grhl3ct/ct;TgGrhl3/0 mice were crossed and off-
spring with genotype Grhl3ct/-; TgGrhl3/0 were intercrossed to gen-
erate experimental litters carrying combinations of the null
allele and theGrhl3-BAC (Table 1).Grhl3-/- andGrhl3ct/ct; TgGrhl3/TgGrhl3
fetuses developed SB as expected. The majority of embryos
with Grhl3ct/- genotype exhibited TFDs, with SB also present in
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Figure 3. Excess expression of Grhl3 results in spinal NTDs owing to failure of PNP closure. (A) Among litters from Grhl3ct/ct;TgGrhl3/0 matings analysed at E8.5–10.5,
the PNP was significantly enlarged among Grhl3ct/ct;TgGrhl3/TgGrhl3 embryos (n = 64) from the 12–15 somite stage onwards (#, significant difference from both other
genotypes, P < 0.001). PNP closure was normalized in Grhl3ct/ct;TgGrhl3/0 embryos (n = 123) compared with Grhl3ct/ct littermates (n = 176) at 28–31 somites (∗, significantly
different from Grhl3ct/ct, P < 0.001). Mean ± SEM values; n = 4–77 embryos/genotype/stage (see Supplementary, Fig. S2 for plot of individual data). (B) Abundance of Grhl3
mRNA varies significantly with genotype at E9.5 and E10.5 (∗P < 0.0001 ANOVA; Holm-Sidak pairwise analysis). For context, we previously found that Grhl3 expression
in ct/ct embryos at E10.5 was ∼50% of that in partially congenic wild-type (+ct) embryos (11). (C) Analysis of individual embryos at E10.5 (28–29 somites) shows that
increased abundance of Grhl3 genomic DNA (in transgenic embryos) results in gene dosage-dependent increase in Grhl3mRNA expression. qG-PCR signal corresponds
to 2, 3 and 4 copies of Grhl3 in ct/ct, hemizygous and homozygous transgenics, respectively. (D) Moderate overexpression of Grhl3 normalizes PNP closure in individual
Grhl3ct/ct;TgGrhl3/0 embryos, compared with Grhl3ct/ct, whereas excess expression prevents PNP closure, in Grhl3ct/ct;TgGrhl3/TgGrhl3 . (E–H) Scanning electron micrographs
at E9 (13 somite stage) show typical appearance of the closing PNP. Neural folds are elevated and apposed in all three genotypes (E–G) but failure of closure progression
is already apparent in Grhl3ct/ct;TgGrhl3/TgGrhl3 embryos (G,H), leaving a narrow unclosed region (compare region adjacent to white arrow E–H). Scale bars represent
0.1 mm.
50% (5 of 10) of embryos, intermediate between that normally
observed in Grhl3ct/ct hypomorphs and Grhl3-/- embryos. Hemizy-
gosity for the transgene normalized neural tube closure irrespec-
tive of the endogenous Grhl3 genotype, with no NTDs arising
in Grhl3ct/ct;TgGrhl3/0 or Grhl3ct/-;TgGrhl3/0 embryos, or most notably in
Grhl3-/-;TgGrhl3/0 that lacks endogenous Grhl3 (Table 1). SB occurred
in only three of eight homozygous null embryos that were also
homozygous for theGrhl3-BAC (Grhl3-/-;TgGrhl3/TgGrhl3; Table 1).Over-
all, these findings suggest that overexpression of Grhl3 is suf-
ficient to rescue the null phenotype and that nullizygosity for
Grhl3 can partially rescue NTDs resulting from Grhl3 overexpres-
sion, highlighting the importance of Grhl3 gene dosage.
Abnormal function of the surface ectoderm is
implicated in causation of spinal NTDs in Grhl3
overexpressing embryos
Partial rescue of NTDs resulting from excess Grhl3 by deletion
of the endogenous allele suggested that the deleterious effect
of Grhl3 overexpression on neural tube closure was localized to
one or more of the endogenous sites of expression, as opposed
to ectopic activity. At E8.5, Grhl3 is expressed in the surface
ectoderm and in the posterior part of the embryo corresponding
to the node-streak border and caudo-lateral epiblast (11). At E9.5,
Grhl3 mRNA is also detected in the neural plate of the PNP and
then, at E10–10.5, also in the hindgut endoderm. Whole mount
in situhybridization (WMISH)ofGrhl3ct/ct;TgGrhl3/TgGrhl3 embryos con-
firmed Grhl3 expression to be more intense but localized in the
same tissues as in wild-type and hemizygous Grhl3-transgenic
embryos (Fig. 4A and B) (11,12). Analysis of Grhl3 expression in
the context of lack of the endogenous allele further confirmed
expression of the transgene in the normal expression domain
(Fig. 4C).
In Grhl3-/- embryos, the timing of closure failure and the
phenotype of conditional knockouts suggest that the earliest
abnormality of spinal neural tube closure results from a defect
in the surface ectoderm (12). The surface ectoderm is the
precursor of the epidermis, in which Grhl3 regulates terminal
differentiation, barrier formation and repair (10,19–21).We asked
whether expression of epithelial/epidermal genes was altered at
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Table 1. Phenotypes of embryos carrying combinations of Grhl3 loss of function and overexpressing alleles
Spinal phenotype % (n)
Genotype No. embryos Straight tail TFDs SB & TFDs P
Grhl3ct/ct 13 77 (10) 15 (2) 8 (1)
Grhl3 ct/ct;TgGrhl3/0 8 100 (8) 0 (0) 0 (0)
Grhl3 ct/ct;TgGrhl3/TgGrhl3 9 11 (1) 11 (1) 78 (7) <0.001
Grhl3ct/- 10 20 (2) 30 (3) 50 (5)
Grhl3 ct/-;TgGrhl3/0 10 100 (12) 0 (0) 0 (0)
Grhl3 ct/-;TgGrhl3/TgGrhl3 10 30 (3) 0 (0) 70 (7) <0.001
Grhl3-/- 11 0 (0) 0 (0) 100 (11)
Grhl3 -/-;TgGrhl3/0 12 100 (12) 0 (0) 0 (0)
Grhl3 -/-;TgGrhl3/TgGrhl3 8 62 (5) 0 (0) 38 (3) <0.001
Offspring of Grhl3ct/-;TgGrhl3/0 intercrosses were assessed at E11.0–18.5 for the presence of NTDs and/or TFDs. NTDs did not arise among embryos heterozygous for the
Grhl3 transgene irrespective of the endogenous genotype. Differences in the number (0, 1 or 2) of Grhl3 transgene copies was associated with significant variation in
the distribution of spinal phenotypes among Grhl3ct/ct, Grhl3ct/- and Grhl3-/- embryos (P < 0.001; Chi-square).
Figure 4. Overexpression of Grhl3 and Cdh1 in Grhl3-transgenic embryos. (A and B) Grhl3 expression in hemizygous (A) and homozygous (B) Grhl3-BAC transgenics
detected by WMISH. Expression is detected in the expected domains in the surface ectoderm (se), neural plate (np) and hindgut (arrows in whole mounts; dotted lines
in sections). Transverse sections are at the level of white dotted line on corresponding whole mount images; sagittal sections are shown at E9.5. (C) On a Grhl3-null
background, the expression pattern of Grhl3 (entirely from the transgene), resembles the previously reported endogenous expression pattern. (D and E) Cdh1 shows the
expected expression in surface ectoderm (se) and gut endoderm (g) in Grhl3ct/ct embryos (D). In Grhl3-transgenic embryos (E), Cdh1 expression appears more intense in
the surface ectoderm (se) and occasional Cdh1-postive cells (arrows in E’-E”’) are present in the recently closed neural tube (nt; L) and the neuroepithelial component
(ne) of the open neural folds (E”’, inset). Figure shows representative embryos at E9.5 (19–20 somite stage; D,E) with site of neural fold closure shown by white arrow in
whole mounts. Scale bar = 0.5 mm in whole mounts; 0.1 mm in sections.
neurulation stages. Using qRT-PCR, we found that known
Grhl3 targets in late-fetal epidermis, Lor and Tgm1, were
already upregulated in the caudal region of Grhl3 overex-
pressing embryos at E10.5 (Supplementary Material, Table S1).
At E9, the stage at which neurulation begins to fail in
Grhl3 mutant embryos, Trp63 (encoding TAp63) (22), a key
transcriptional regulator of epidermal specification, was also
upregulated in Grhl3ct/ct;TgGrhl3/TgGrhl3 (Supplementary Material,
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Table S2), suggesting abnormal specification of the sur-
face ectoderm. This correlates with the finding that Trp63
is downregulated in Grhl3 null embryos at the same stage (12).
Cdh1 (encoding E-cadherin) is a key marker of surface
ectoderm, a direct target of Grhl3 in mouse mammary gland
cells (23) and upregulated in skin of Grhl3-transgenics at E18.5
(Supplementary Material, Fig. S6C). In the caudal region of
Grhl3-transgenic embryos at E9.5 and 10.5, we observed a non-
significant trend towards upregulation of Cdh1 (Supplementary
Material, Tables S1 and S2). As expression in the surface
ectoderm comprises only a subset of the Cdh1 expression
domain we further examined expression by in situ hybridization
at E8.5–10.5. Expression was observed at expected sites in the
surface ectoderm and hindgut, with noticeably more intense
staining in the surface ectoderm in Grhl3ct/ct;TgGrhl3/TgGrhl3 embryos
compared with Grhl3ct/ct (Fig. 4D–E). Cells expressing Cdh1
were also present at ectopic locations in the neuroepithelium
of the PNP and tailbud of Grhl3ct/ct;TgGrhl3/0 and most notably
Grhl3ct/ct;TgGrhl3/TgGrhl3 embryos (Fig. 4D–E and Supplementary
Material, Fig. S3). Ectopic E-cadherin protein expression was also
confirmed by immunohistochemistry (Supplementary Material,
Fig. S3). We hypothesize that earlier overexpression of Grhl3
in the node-streak border and caudo-lateral epiblast, which
contains precursors of the neuroepithelium and mesoderm
(neuromesodermal progenitors) (24), and in the neural plate
may lead to persistent expression of Cdh1, such that expression
is not downregulated in a subset of neuroepithelial cells. This
idea is consistent with the observation of Cdh1-positive cells in
ectopic locations within the tailbud. Given the sparse nature of
Cdh1-expressing cells in the neural plate it seems unlikely that
they have a significant deleterious effect on closure, particularly
as elevation of the neural folds does not appear compromised in
Grhl3 overexpressing embryos.
The premature upregulation of markers such as Trp63, Lor
and Tgm1, and the abnormal expression of Cdh1, suggest that
NTDs caused by Grhl3 gain of function could result primarily
from dysregulation of gene expression in the surface ectoderm.
A contribution from other Grhl3 expressing tissues appears
unlikely as follows: overexpression of Grhl3 in the neural plate
occurs prior to closure failure but there is no obvious defect
in neural fold elevation (Fig. 3). Grhl3 is expressed in the node-
streak border and caudo-lateral epiblast (Fig. 4A) but we found
no evidence for altered patterning of the caudal region in Grhl3
overexpressing embryos (Supplementary Material, Fig. S4). Loss
of function of Grhl3 in the hindgut alone is sufficient to prevent
closure at late stages of spinal neurulation (12). However, inGrhl3
overexpressing embryos, closure fails prior to onset of hindgut
expression (Figs 3 and 4) and there is no increase in ventral
curvature (Supplementary Material, Fig. S5), the mechanism
by which insufficient Grhl3 expression in the hindgut inhibits
closure (13).
Overexpression of Grhl3 does not exacerbate cranial
NTDs or cause skin barrier defects
In addition to SB, loss of function of Grhl3 has been shown to
cause cranial NTDs (exencephaly) and epidermal defects (9,10).
We therefore asked whether overexpression of Grhl3 recapitu-
lates these phenotypes.
InGrhl3-/- models, the frequency of exencephalywas reported
as 2% and 14% (9,10). Unlike SB this is not markedly higher than
in the curly tail strain, in which exencephaly typically affects 6–
8% of embryos (25–27). AmongGrhl3ct/ct;TgGrhl3/0 intercrosses, exen-
cephaly occurred in a similar proportion of transgene-negative
Grhl3ct/ct (13/181; 7.2%) and transgene-positive (Grhl3ct/ct;TgGrhl3/0
and Grhl3ct/ct;TgGrhl3/Grhl3) embryos (39/487; 8.0%). Among 147 of
these transgene-positive embryos genotyped by gPCR, the
proportion of exencephalic embryos did not differ between
BAC-hemizygotes and homozygotes. Hence, in contrast to the
striking effect on SB, overexpression of Grhl3 in the cranial
region of Grhl3ct/ct;TgGrhl3/TgGrhl3 embryos (confirmed by qRT-PCR;
Supplementary Material, Fig. S1C) did not cause a significant
increase in frequency of cranial NTDs. Moreover, as we found
previously, cranial NTDs in the ct strain were not rescued by
upregulation of Grhl3 in the cranial region of Grhl3ct/ct;TgGrhl3/0
embryos (27). These findings support the hypothesis that
diminished Grhl3 expression is not the main cause of cranial
NTDs in the ct strain and that the underlying mechanism
therefore differs from Grhl3-null embryos. Instead, the principal
contribution may be from other deleterious variants in the ct
genetic background, Lmnb1 and Mthfd1L having been identified
as potential modifiers of NTDs in the ct strain (25,27).
Grhl3 is required for differentiation and repair of the epider-
mal barrier at late fetal stages (10) and for post-natal repair of
the epidermal barrier after injury (21). Skin histology of Grhl3-
null fetuses becomes abnormal by E16.5, while the epidermal
permeability barrier, which normally begins to form at E16–
17, fails to develop by E18.5 (10). In the Grhl3 null/transgenic
crosses in the current study, we confirmed that the epidermal
barrier fails to form in Grhl3-/- fetuses, using a dye penetration
assay (Fig. 5A and B). The skin barrier was complete by E18.5
in 6/6 wild-type and 16/16 Grhl3+/- fetuses but not in Grhl3-/-
littermates (0/5). Transgenic expression of Grhl3 was sufficient
to rescue the epidermal barrier defect phenotype in Grhl3-/-
fetuses, both in hemizygous (Grhl3-/-;TgGrhl3/0) and homozygous
(Grhl3+/-;TgGrhl3/TgGrhl3) transgenics (3/3 of each genotype tested)
(Fig. 5). Known Grhl3 targets in the epidermis were upregulated
in skin at E8.5 (Fig. 5D). However, in contrast to the NTDs pro-
duced by overexpression of Grhl3, we did not observe epider-
mal abnormalities in Grhl3+/+;TgGrhl3;TgGrhl3 fetuses (barrier com-
plete in 3/3; Fig. 5). The histological appearance of skin in Grhl3-
overexpressing fetuses was also comparable to controls at E18.5,
with normal staining for the basal marker p63 (Supplementary
Material, Fig. S6).
Additional phenotypes reported in Grhl3-null fetuses include
the presence of open eyelids at E18.5 and an abnormal
limb phenotype (28). During normal development, the digits
become separated by E15 and then undergo a temporary epithe-
lial fusion, with displacement of intervening periderm cells (29).
Digit fusion appears to occur normally in Grhl3-null fetuses but
the distal limb appears swollen (28) (Fig. 5C). Consistent with
normal barrier formation in Grhl3 overexpressing embryos, limb
development was also apparently normal (Fig. 5B). In contrast,
the open-eye phenotype that accompanies SB in Grhl3-null
fetuses was also present in Grhl3 transgenics with SB at E18.5,
whether wild type or mutant at the endogenous Grhl3 locus.
Genetic interaction of Grhl3 and Grhl2 overexpression
alleles
Grhl2 and Grhl3 both form homodimers but also exhibit
protein–protein interactions to form heterodimers (30,31),
although the functional role of these interactions is unknown.
We speculated that excessive abundance of Grhl3 could
disturb the relative abundance of Grhl2 and Grhl3 proteins
and favour formation of heterodimers, thereby inhibiting
function of Grhl2 homodimers and causing spinal NTDs
(as observed in Grhl2-null embryos) (32). Similarly, it could
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Figure 5. Establishment of the epidermal barrier is not compromised by Grhl3 overexpression. (A–C) Integrity of the permeability barrier was determined by dye
penetration assay. At E16.5 (A), all genotypes show dye penetration, whereas at E18.5 (B) Grhl3-/- is the only genotype with incomplete epidermal barrier. Note that
barrier formation is rescued by transgenic expression of Grhl3 in Grhl3-/-;TgGrhl3/TgGrhl3 fetuses (in parallel with rescue of NTDs). Although Grhl3 overexpression causes
SB, the epidermal barrier is established by E18.5 in hemizygous and homozygous transgenics. Note that limbs appear normal in transgenic fetuses, unlike in Grhl3-/-
(∗, abnormal forelimbs in B,C). Moreover, partially or completely open eyelids are visible in the transgenic fetuses (B). Scale bar represents 1 mm; CT: curly tail; ST:
straight tail. (D) Analysis of gene expression in E18.5 skin samples in litters from compound mutant/transgenic or Grhl3ct/ct;TgGrhl3/0 intercrosses shows that Grhl3
overexpression is associated with increased expression of Lor, Tgm1 and Cdh1 (significant differences from Grhl3ct/ct: ∗P < 0.05, ∗∗P < 0.001; ANOVA).
be predicted that spinal NTDs caused by overexpression
of Grhl2 in Axd mutants could result from suppression of
Grhl3 function. These models predict that overexpressing
Grhl2 in Grhl3-transgenic embryos would normalize
spinal neural tube closure by compensating for excess of
Grhl3. To test this hypothesis we generated embryos that
overexpress both Grhl2 and Grhl3, by intercross of Axd/+
and +/+TgGrhl3/0 mice. Spinal NTDs occurred only at very
low frequency in single heterozygotes as expected (Fig. 6A).
Remarkably, however, a large SB was observed in 100%
(n = 19) of doubly heterozygous Axd/+; +/+TgGrhl3 embryos
(Fig. 6A–C). Analysis of a further series of embryos collected at
E9.0–10.5 showed that doubly heterozygous embryos exhibit
failure of closure, with a significantly enlarged PNP from
E9.5 (15–19 somites stage) onwards (Fig. 6D). We confirmed
that expression of Grhl2 and Grhl3 was elevated in the
embryos carrying the Grhl2Axd allele and Grhl3 transgene,
respectively (Fig. 6E), without evidence of reciprocal regulation.
Hence, occurrence of SB results from an additive genetic
interaction of the Grhl2 and Grhl3 alleles, and we can rule out a
mechanism of NTDs based on mutual repression of function by
gene overexpression.
The Vangl2Lp allele genetically interacts with Grhl3
overexpression to cause SB
We next asked whether moderate overexpression of Grhl3
interacts with another genetic risk factor for NTDs, the
loop-tail (Lp) mutation in Vangl2, encoding a core component
of the PCP signalling pathway. Homozygosity for Vangl2Lp
causes the severe NTD craniorachischisis, (33,34), while
heterozygosity for Vangl2 can also cause craniorachischisis
or SB when in combination with mutant alleles of other
genes including Fzd2, Ptk7, Scrib and Sdc4 (35–37).
Previous studies have also demonstrated genetic interaction
ofVangl2Lp with the loss of functionGrhl3ct- andGrhl3-null alleles
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Figure 6. Genetic interaction betweenGrhl2 andGrhl3 overexpressing alleles results in severe SB. (A–C) Among experimental litters generated by intercross ofGrhl2Axd/+
and Grhl3+/+:TgGrhl3/0 mice, all compound heterozygous fetuses exhibited severe SB. Note the very large size of the SB lesion that extends as far rostrally as the
forelimb bud at E13.5 (C) (∗P < 0.001; significant difference among genotypes, Chi-square). (D) Analysis of PNP length among embryos at E9–10.5 shows that compound
heterozygous, Grhl2Axd/+ ;Grhl3+/+:TgGrhl3/0 embryos have significantly enlarged PNPs from E9.5 (15–19 somite stage) onwards (∗, significant difference from all other
genotypes, P < 0.001). At E10.5 (28–31 somites) the PNP length of Grhl2Axd/+ ;Grhl3+/+;TgGrhl3/0 embryos is also greater than in wild type (#, P < 0.01). (E) In the caudal
region of E9.5 embryos, mRNA abundance of Grhl2 and Grhl3 corresponds with the presence of the Grhl2Axd and Grhl3TgGrhl3 alleles, with no indication of reciprocal
regulation (∗, differences from wild-type expression level, P < 0.01).
(38,39). We intercrossed Vangl2Lp/+ mice with Grhl3ct/ct;TgGrhl3/0
transgenics and analysed litters of embryos at E11.5
(Table 2). TFDs occurred in almost all Vangl2Lp/+;Grhl3ct/+ double
heterozygotes, correlating with the almost complete penetrance
of this defect in Vangl2 heterozygotes in the loop-tail strain (37).
Strikingly, SB developed in 77% of Vangl2Lp/+;Grhl3ct/+;TgGrhl3/0
embryos, but not among embryos of any other genotype,
demonstrating additive interaction of Vangl2Lp and the Grhl3-
transgene (Table 2a).
In a second experimental cross, Vangl2Lp/+;Grhl3ct/+ double
heterozygotes were intercrossed with Grhl3ct/ct;TgGrhl3/0 trans-
genics (Table 2b). Among litters analysed at E11.5 a high
frequency of SB occurred in Vangl2Lp/+;Grhl3ct/ct embryos,
confirming previous findings (38). However, in contrast to the
preventive effect of hemizygosity for the Grhl3-BAC on NTDs
in Grhl3ct/ct and Grhl3-/- embryos (Table 1), the presence of the
Grhl3-transgene did not prevent the NTDs in Vangl2Lp/+;Grhl3ct/ct
embryos (Table 2b). These findings provide further evidence for
an exacerbating combinatorial effect of Vangl2 mutation and
Grhl3 overexpression on spinal neural tube closure. This does
not appear to involve direct regulation of Vangl2 expression
by Grhl3 as altered Vangl2 expression was not associated
with Grhl3 loss of function in our previous transcriptomic
analyses (10,21,27) or in qRT-PCR analysis of Grhl3+/+ and
Grhl3-/- embryos at E9.5 (P > 0.05; three or more per geno-
type). Similarly, Vangl2 expression did not differ between
Grhl3ct/ct, Grhl3ct/ct;TgGrhl3/0 or Grhl3ct/ct;TgGrhl3/TgGrhl3 embryos at E9.5
(P > 0.05; three or more per genotype). Moreover, Grhl3 binding
sites were not identified in the 10 kb region upstream of
Vangl2 (39).
Discussion
A requirement for sufficient Grhl3 expression to enable spinal
neural tube closure is shown by the presence of SB in Grhl3-
null embryos (10), hypomorphic Grhl3ct/ct embryos (11) and in
tissue-specific knockouts (12). In the current study we found
that overexpression of Grhl3 also causes SB, emphasizing the
exquisite sensitivity of the closure process to the abundance of
Grhl3 (Table 3). The induction of SB by excess Grhl3 appears to
involve a defect in the surface ectoderm: PNP closure fails soon
after initiation of closure when Grhl3 is strongly expressed in the
surface ectoderm bordering the PNP and is not associated with
a defect of neural fold elevation or altered molecular patterning
of the caudal region.Moreover,Grhl3 overexpressing embryos do
not exhibit the excess body curvature that results fromGrhl3 loss
of function in the hindgut and prevents the later stages of PNP
closure (12).
The Grhl3 transgene is expressed in the endogenous domain
during neural tube closure and rescue of SB by the presence of
the transgene inGrhl3ct/ct andGrhl3-/- embryos shows that the tar-
get genes necessary for neurulation are appropriately regulated.
Similarly, rescue of skin barrier defects shows that key epidermal
genes are activated in the correct spatiotemporal manner. Grhl3
is known to regulate numerous genes in the epidermis (derived
from the surface ectoderm) at late-fetal and post-natal stages,
including cell adhesion molecules, lipid metabolizing enzymes
and structural proteins of the stratum corneum (10,19–21).
The genome-wide binding pattern of Grhl3 appears dynamic
with regulation of distinct sets of genes depending on the
functional state of the epidermis. For example, comparison
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Table 2. Genetic interaction between Grhl3 and Vangl2Lp alleles results in severe SB
Spinal Phenotype % (n)
Genotype No. embryos Straight tail TFDs SB & TFDs
a. Vangl2Lp/+ × Grhl3ct/ct TgGrhl3/0
Vangl2+/+;Grhl3ct/+ 4 100 (4) 0 (0) 0 (0)
Vangl2+/+;Grhl3ct/+;TgGrhl3/0 11 55 (6) 45 (5) 0 (0)
Vangl2Lp/+;Grhl3ct/+ 12 8 (1) 92 (11) 0 (0)
Vangl2Lp/+;Grhl3ct/+ TgGrhl3 13 0 (0) 23 (3) 77 (10)∗
b. Vangl2+/+;Grhl3ct/ct TgGrhl3/0 × Vangl2Lp/+;Grhl3ct/+
Vangl2+/+;Grhl3ct/+ 14 86 (12) 14 (2) 0 (0)
Vangl2+/+;Grhl3ct/ct 11 55 (6) 45 (5) 0 (0)
Vangl2+/+;Grhl3ct/+;TgGrhl3/0 9 78 (7) 22 (2) 0 (0)
Vangl2+/+;Grhl3ct/ct;TgGrhl3/0 8 88 (7) 12 (1) 0 (0)
Vangl2Lp/+;Grhl3ct/+ 6 0 (0) 100 (6) 0 (0)
Vangl2Lp/+;Grhl3ct/ct 9 0 (0) 22 (2) 78 (7)
Vangl2Lp/+;Grhl3ct/+;TgGrhl3 11 0 (0) 82 (9) 18 (2)
Vangl2Lp/+;Grhl3ct/ct;TgGrhl3 11 0 (0) 55 (6) 45 (5)
(a)Among experimental litters generated by intercross of Grhl3ct/ct;TgGrhl3/0 with Vangl2Lp/+ , SB occurred at high frequency in embryos carrying both the Grhl3 transgene
and the Vangl2Lp allele, but was not observed among embryos carrying either allele alone (∗P < 0.05; Chi square). (b) Embryos that are heterozygous or homozygous for
the Grhl3ct allele but are wild type for Vangl2 display partially penetrant TFDs. Doubly heterozygous (Vangl2Lp/+;Grhl3ct/+) embryos display TFDs, correlating with 100%
penetrance of this defect among Lp/+ mice. SB occurs with high frequency among Lp/+;Grhl3ct/ct embryos as reported previously (38). Unlike our finding in Grhl3ct/ct
(Gustavsson et al., 2007) and Grhl3-/- embryos (Table 1), this defect is not rescued by the Grhl3 transgene supporting the hypothesis that SB in embryos carrying the
Vangl2Lp and Grhl3 transgene, results from an additive genetic interaction. Litters analysed at E11.5 (n = 6 and 9 litters in a and b, respectively).
Table 3. Summary of the relationship between spina bifida (SB) frequency andGrhl3 abundance among embryos carrying different combinations
of endogenous Grhl3 allele and Grhl3 transgene
Genotype & NTDs
Grhl3 locus -/- ct/- ct/ct +/- +/+ ct/- ct/ct +/+ -/- ct/- ct/ct
Grhl3 transgene 0/0 0/0 0/0 0/0 0/0 Tg/0 Tg/0 Tg/0 Tg/Tg Tg/Tg Tg/Tg
SB (%) 100 50 10 0 0 0 0 15 38 70 70
Increasing Grhl3 expression →
Grhl3 expression 0 ∼0.5 ∼0.5 1 ∼1.5 ∼2 2.5-3
Indicative expression levels (approximate) are based on collation of qRT-PCR data within differing experimental crosses. The frequency of spina bifida (SB) refers to
approximate percentage of embryos with SB among each specific genotype.
of epidermis during differentiation and during re-establishment
of the epidermal barrier following post-natal injury shows
overlap of Grhl3 targets, but more than half of the binding
events differed (21). The potential for context-dependent
and diverse transcriptional regulatory activity of Grhl3 suggests
that the requirement during neural tube closure could involve
overlapping and/or distinct functions compared with later
epidermal differentiation and repair. Notwithstanding the
possible difference in Grhl3 targets at different stages, we
found a subset of epidermal and epithelial markers to be
upregulated in Grhl3 overexpressing embryos at neurulation
stages, suggesting a potential dysregulation of surface ectoderm
properties. Such an effect could be incompatible with closure,
consistent with the site of initial contact of the neural folds
being mediated by surface ectoderm cells at the border with the
neural plate (40).
The finding that both insufficient and excess abundance
of Grhl3 cause SB is similar to observations with Grhl2, null
alleles of which cause cranial and spinal NTDs (32,41,42), while
upregulation causes SB (32). Interestingly, while Grhl2- and
Grhl3-null embryos exhibit multiple defects alongside NTDs
(e.g. skin barrier, urothelial differentiation, kidney and placental
defects) (10,41,43,44), we found that their overexpression
counterparts display isolated SB that more closely resembles
the corresponding human condition.
Overall, findings in mouse models suggest that GRHL2
and GRHL3 represent strong candidates for potential involve-
ment in human NTDs, with the consideration that not only
loss-of-function variants but also regulatory and gain-of-
function mutations could plausibly play a role. In addition to
the development of NTDs in homozygous transgenic embryos
it is notable that even moderate overexpression of Grhl3 was
sufficient to cause SB when in combination with heterozygous
mutations in Grhl2 or Vangl2. Such gene–gene interactions
appear likely to more closely resemble the multigenic etiology
of human NTDs than single gene mutants.
Materials and Methods
Mice
Curly tail mice were maintained as a homozygous, closed
random-bred colony. The transgenic curly tail line Grhl3ct/Grhl3ct;
D
ow
nloaded from
 https://academ
ic.oup.com
/hm
g/article-abstract/27/24/4218/5090855 by U
niversity C
ollege London user on 27 February 2019
Human Molecular Genetics, 2018, Vol. 27, No. 24 4227
Tg(Grhl3)1Ndeg (MGI:3794067), here denoted as Grhl3ct/ct;TgGrhl3/0,
carries a BAC that encompasses theGrhl3 gene (11). Homozygous
transgenics were generated by intercross of Grhl3ct/ct;TgGrhl3/0
mice. The mutant line carrying a conditional (floxed) allele
of Grhl3 (designated Grhl3f/+) has been described (10). These
mice were crossed to β-actin-Cremice to generate heterozygous-
null, Grhl3+/-, mice used in subsequent experimental matings.
To generate embryos carrying combinations of Grhl3 alleles
with the Grhl3-BAC we crossed Grhl3+/- and Grhl3ct/ct;TgGrhl3/0
mice. The offspring with genotype Grhl3ct/-;TgGrhl3/0 were inter-
crossed to generate experimental litters.
To transfer the Grhl3-BAC onto a partial BALB/c genetic
background, Grhl3ct/ct;TgGrhl3/0 mice were backcrossed with
wild-type BALB/c mice for three generations. Grhl3+/+;TgGrhl3/0
were either intercrossed to generate experimental litters
or crossed with Axd/+ mice on a BALB/c genetic background (32),
to generate litters containing double heterozygotes.
Mice carrying the loop-tail allele of Vangl2 were on a CBA/Ca
background.
Animal studies were carried out under regulations of
the Animals (Scientific Procedures) Act 1986 of the UK Gov-
ernment, and in accordance with guidance issued by the
Medical Research Council, UK in Responsibility in the Use of
Animals for Medical Research (July 1993). Mice were used for
experimental matings from 6 weeks of age. Litters were
generated by timed matings in which mice were paired
overnight and the day of finding a copulation plug was
designated embryonic day 0.5 (E0.5). Pregnant females were
killed by cervical dislocation. The uterus was removed and
transferred to Dulbecco’s Modified Eagles Media (DMEM; Invit-
rogen) containing 10% fetal bovine serum (heat inactivated at
58◦C; Invitrogen).
The PNP length of embryos at E8.5–E10.5 was measured
using an eyepiece graticule. The PNP was defined as the
distance from the tip of the tail bud to the rostral limit of the
open neural folds. For measurements of ventral curvature, the
caudal region of E9.5–10.5 embryos was isolated from the body,
photographed, and curvature of the caudal region measured as
described (13,32). Briefly, as shown in Supplementary Material,
Figure S6, the angle was determined in side views of the caudal
region between a line tangential to the ventral edge of the
penultimate somite and a line drawn along the midline of
the tail bud, parallel to and equidistant from the ventral and
dorsal surfaces.
Genotyping
Mice were genotyped by PCR of genomic DNA, as described (10,
11,45). Mice carrying the Grhl3 BAC-transgene were genotyped
by PCR using a BAC-specific primer (11) and gene dosage
determined by quantitative real-time genomic PCR (qG-PCR)
on DNA isolated from individual yolk sacs amplified using
RealTime PCR Mesa Blue qPCR Master Mix Plus for SYBR
assay (EUROGENTEC), or iTAQ Universal SYBR Green Supermix
assay (Bio-Rad). A Grhl3 intronic sequence was amplified
with normalization to a reference gene (Grhl2), whose copy
number is unchanged between strains. Each assay experiment
included at least one Grhl3ct/ct sample as calibrator and one
hemizygous transgenic sample, for which the genotype was
known (BAC-positive embryos from crosses between Grhl3ct/ct
and Grhl3TgGrhl3/0 mice). These samples provided an index level
for the copy number of Grhl3 in hemizygous transgenic, for
comparison with the ‘unknown’ hemizygous or homozygous
transgenic BAC-positive samples. PCR amplification of the
transgene appeared more efficient than the endogenous Grhl3
locus such that relative signal was 1 (2 endogenous copies),
2 (2 endogenous + 1 transgene) and 3 (2 endogenous + 2
transgene) (Fig. 3C).
BAC localization by inverse PCR
DNA was extracted from transgenic embryos using the QIAamp
DNA Mini kit (Qiagen), digested with RsaI (Invitrogen) or
HaeIII (Fermentas), circularized and re-linearized with BamHI
(Promega). The linearized product was then amplified by PCR
with BAC inverse primers (327D13-R1 inverse 5′-CCCTAATGATG
ACCACGTGA-3′ and pTARBAC-R inverse 5′-TAGTGTCACCTAAAT
GTCGAC-3′). PCR products were separated on a 1% agarose gel
and all obvious bands were excised from the gel and purified
using QIAquick Gel Extraction kit (Qiagen). DNA was eluted
in water for subsequent sequencing with each of the inverse
primers (BigDye Terminator Cycle Sequencing kit, Applied
Biosystems).
Sequence tags did not show 100% identity with a specific
chromosomal location owing to variation between the unique
curly tail genetic background and the C57BL/6 reference
sequence. However, sequences generated from inverse PCR
were aligned to the reference genomic sequence, with closest
homology to a region on chromosome 18 that indicates insertion
of the BAC at 18: 3,005,382 in a low complexity repeat. A series
of primers (R1–R5; Supplementary Material, Table S5) comple-
mentary to chromosome 18 were used to amplify genomic DNA
with the BAC-specific primer (pTARBAC-Rinv) (Supplementary
Material, Fig. S1). To confirm localization genomic PCR was
performed using a BAC specific primer (pTARBAC-R inverse) with
a series of primers located in chromosome 18 (Supplementary
Material, Table S4).
Preparation of blood cultures and FISH
Interphase nuclei were prepared on slides using peripheral blood
from curly tail and hemizygous Grhl3 transgenic male mice.
FISH analysis was performed on DAPI-stained interphase nuclei
spreads on slides according to standard procedures using the
BAC probe RP24-327D13 (BACPAC Resources Center at Childrens
Hospital Oakland Research Institute).
Whole mount in situ hybridization was performed as previ-
ously reported (25). For sectioning, embryos were embedded in
albumin-gelatine and 40 μm sections obtained on a vibratome
(Leica VT 1000S, Leica Microsystems). Photography of whole
embryos was performed on a stereo microscope (Leica MZFLIII
microscope) using a Leica DC500 camera. Bright-field image
acquisition of sectionswas performedwith anAxiophot 2micro-
scope (Zeiss) with Leica DC500 camera software (AxioVision).
Images were processed using Photoshop (Version 6.0) for crop-
ping and figures were prepared using Adobe Illustrator software.
Cdh1-positive cells were counted on serial 40 μm sections
after WMISH for Cdh1. For each embryo the total number of
ectopic cells was divided by the total number of sections. The
mean and the standard error of the mean (mean ± SEM) were
plotted for different genotypes. To analyse the axial distribution
of Cdh1 positive cells in the neuroepithelium, four regions were
defined and for each region the total number of positive cells
per section was calculated as a percentage of the total number
of sections (all embryos combined at each stage).
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Whole-mount antibody staining
4% PFA-fixed, methanol-dehydrated whole E8.5–E9.0 embryos
were post-fixed (methanol/DMSO) overnight at 4◦C. After
bleaching (methanol/DMSO/30% H2O2) at room tempera-
ture for 4 h, embryos were blocked (phosphate buffered
saline (PBS) containing 10% heat-inactivated Sheep serum/2%
Bovine Serum Albumin/0.5% Triton X-100) for 4 h. Primary
purified mouse anti-Ecadherin (BD Transduction Lab, 1:150
dilution) and relevant secondary (Alexa Fluor 488 goat anti-
mouse, Life Technologies, 1/500) antibodies were applied
in the same blocking solution overnight at 4◦C. All the washes
were performed with PBS 0.5% Triton X-100. Embryos were
counterstained with DAPI for 2 h at room temperature. Prior
to imaging, embryos were incubated in Scale A2 for clearing
the tissue. Embryos were positioned in ‘wells’ cut into 4%
agarose gels such that the PNP faced upwards. All images
were captured on a Zeiss Examiner LSM880 confocal micro-
scope using a 20x/NA1.0 Plan Apochromat dipping objective
immersed in PBS. Low-magnification images were captured at
0.7× zoom with a pixel size of 0.6 μm and a Z step of 2 μm.
High-magnification images were taken at 2× zoom with a
pixel size of 0.1 μm and a Z step of 2 μm. Salt and pepper
noise was subtracted, brightness and contrast were adjusted
evenly across each image and maximum intensity projections
were obtained in Fiji (ImageJ, NIH, PMID 22743772). Digital
reslicing of confocal Z-stacks was also performed in Fiji, as
previously (46).
Quantitative real-time PCR
RNA was isolated from the caudal region of E8.5 (10–14ss,
cut at somite 10), E9.5 (15–16ss, cut at somite 12) and E10.5
(26–31ss, cut at somite 14) embryos, and the cranial region, ros-
trally from the level of the otocyst (excluding branchial arches).
Total RNA was isolated using TRIzol Reagent (Gibco) followed
by DNase treatment (DNA-free, Ambion). cDNA was generated
using the SuperScript VILO kit (Invitrogen) or SuperScript II
Reverse Transcriptase (RT) kit (Invitrogen). Normalization was
performed using glyceraldehyde-3-phosphate dehydrogenase
(Gapdh) as (11). Quantitative RT-PCR was performed using iTAQ
Universal SYBR Green Supermix assay (Bio-Rad) on a CFX96
system (Bio-Rad) with analysis using Bio-Rad CFX Manager
software (see Supplementary Material, Table S5 for primer
sequences). For each experiment a calibrator sample was chosen
to normalize levels of cDNA expression. Individual experiments
were combined and analysed using SigmaStat v 3.5 software
(ANOVA or t-test).
Supplementary Material
Supplementary Material is available at HMG online.
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